Journal article
Evaluation of preexposure (PrEP) eligibility criteria, using sexually transmissible infections as markers of human immunodeficiency virus (HIV) risk at enrollment in PrEPX, a large Australian HIV PrEP trial
VJ Cornelisse, CK Fairley, M Stoove, J Asselin, EPF Chow, B Price, NJ Roth, J Willcox, BK Tee, M Penn, CC Chang, J Armishaw, G Forgan-Smith, EJ Wright
Clinical Infectious Diseases | OXFORD UNIV PRESS INC | Published : 2018
DOI: 10.1093/cid/ciy370
Abstract
Background. To determine participants’ human immunodeficiency virus (HIV) risk, the Australian preexposure prophylaxis (PreEPX) trial used 6 eligibility criteria derived from the US Centers for Disease Control and Prevention PrEP guidelines. Participants who fulfilled no eligibility criteria could be enrolled if clinically assessed to need PrEP. This study evaluated whether PREPX eligibility criteria correlated with biological HIV risk markers—namely, syphilis, anorectal chlamydia, or anorectal gonorrhea (sexually transmitted infections [STIs]). Methods. We calculated adjusted odds ratios (aORs) to assess whether eligibility criteria predicted STI diagnoses at enrollment. Results. We include..
View full abstractGrants
Awarded by Abbott Laboratories
Funding Acknowledgements
The PrEPX study was supported by funding from the Victorian Department of Health and Human Services and the Victorian AIDS Council. V.J.C. receives a stipend from the Research Training Program of the Australian Government's Department of Education and Training. M. S. is supported by a National Health and Medical Research Council Senior Research Fellowship. C. C. is supported by an National Health and Medical Research Council Early Career fellowship (APP1092160).